CID 71301017

(3-alpha,16-alpha)-eburnamenin-14(15h)-one oxime hydrochloride

Structural Information

Molecular Formula
C19H23N3O
SMILES
CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4/C(=N\O)/C2
InChI
InChI=1S/C19H23N3O/c1-2-19-9-5-10-21-11-8-14-13-6-3-4-7-15(13)22(16(12-19)20-23)17(14)18(19)21/h3-4,6-7,18,23H,2,5,8-12H2,1H3/b20-16-/t18-,19+/m1/s1
InChIKey
HPVDZBKXWQJQRP-FVQWEEDQSA-N
Compound name
(NZ)-N-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-ylidene]hydroxylamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

309.1841 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 310.191376 171.3
[M+Na]+ 332.173318 178.3
[M-H]- 308.176824 173.3
[M+NH4]+ 327.217923 191.1
[M+K]+ 348.147258 171.8
[M+H-H2O]+ 292.181360 161.3
[M+HCOO]- 354.182301 183.6
[M+CH3COO]- 368.197951 180.6
[M+Na-2H]- 330.158766 177.1
[M]+ 309.18355142 169.4
[M]- 309.18464858 169.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.